Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aura Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aura Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Person Julie | Chief People Officer | 107,611 | Sep 1, 2026 | 1 |
| Kratz Erica | Chief Reg. & Quality Officer | 100,885 | Sep 1, 2026 | 1 |
| Hopkins Janet Jill | Chief Medical Officer | 380,190 | Sep 1, 2026 | 4 |
| Elazzouzi Amy | SVP, Finance & PAO | 143,600 | Sep 1, 2026 | 5 |
| Abu-Absi Susan | Chief Operating Officer | 134,513 | Sep 1, 2026 | 1 |
| Bender Jeremy | Director | 30,000 | Jul 8, 2026 | 1 |
| Kilroy Conor | See Remarks | 232,693 | Jul 1, 2026 | 4 |
| Gibney Anthony S | See Remarks | 265,354 | Jun 16, 2026 | 2 |
| Srivastava Sapna | Director | 38,500 | Jun 15, 2026 | 1 |
| Mattessich Antony C. | Director | 38,500 | Jun 15, 2026 | 1 |
| Johnson David Michael | Director | 194,167 | Jun 15, 2026 | 1 |
| Bitetti Teresa Marie | Director | 36,000 | Jun 15, 2026 | 1 |
| Holles Natalie C. | See Remarks | 1,153,962 | May 19, 2026 | 1 |
| Matrix Capital Management Company, LP | 10% Owner | 0Indirect | May 11, 2026 | 1 |
| Goel David E. | 10% Owner | 0Indirect | May 11, 2026 | 1 |
| Plavsic Mark | Chief Technology Officer | 243,736 | Mar 3, 2026 | 3 |
| de los Pinos Elisabet | See Remarks | 575,815 | Mar 3, 2026 | 4 |
| Feder Julie B | Chief Financial Officer | 134,276 | Oct 21, 2024 | 0 |
| Parekh Rajesh B | Director | – | Jun 9, 2023 | 0 |
| De Rosch Mark | Chief Operating Officer | 58,635 | Jan 23, 2023 | 0 |
| Rich Cadmus | See Remarks | 58,703 | Jan 23, 2023 | 0 |
| Medicxi Growth I LP | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Growth Co-Invest I LP | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Growth I GP Ltd | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Primiano Christopher Brett | Chief Business Officer | 8,750 | Oct 29, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 (view filing) | Jun 16 | Same day | Gibney Anthony SSee Remarks | SSale | −12.8K | $6.42 | −$82.3K | −4.6%265.4K after | |
| May 11, 2026 (view filing)4:16 PM ET | May 7 | 4 days | Matrix Capital Management Company, LP and 1 other10% Owner | SSaleCommon Stock, par value $0.00001 per share (Common Stock) | −6.92M | $5.64 | −$39.0M | −100.0%0 after | |
| Apr 16, 2026 (view filing) | Apr 16 | Same day | Kilroy ConorSee Remarks | SSale | −11.7K | $7.02 | −$82.4K | −5.1%217.8K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | Kilroy ConorSee Remarks | SSale | −12.1K | $5.05 | −$61.0K | −6.7%167.2K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | Plavsic MarkChief Technology Officer | SSale | −15.9K | $5.05 | −$80.2K | −8.1%181.4K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | Hopkins Janet JillChief Medical Officer | SSale | −20.4K | $5.06 | −$103.2K | −8.1%232.3K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −8.55K | $5.06 | −$43.3K | −10.2%75.5K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | de los Pinos ElisabetSee Remarks | SSale | −47.6K | $5.06 | −$241.1K | −10.4%409.8K after | |
| Jan 20, 2026 (view filing) | Jan 20 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −1.58K | $4.86 | −$7.68K | −1.8%84.1K after | |
| Jan 20, 2026 (view filing) | Jan 20 | Same day | de los Pinos ElisabetSee Remarks | SSale | −16.9K | $4.86 | −$82.3K | −3.6%457.5K after | |
| Nov 17, 2025 (view filing) | Nov 17 | Same day | Hopkins Janet JillChief Medical Officer | SSale | −17.1K | $5.42 | −$92.7K | −6.3%252.7K after | |
| Oct 29, 2025 (view filing) | Oct 29 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −896 | $6.35 | −$5.69K | −1.0%85.7K after | |
| Oct 29, 2025 (view filing) | Oct 29 | Same day | de los Pinos ElisabetSee Remarks | SSale | −9.05K | $6.35 | −$57.5K | −1.9%474.4K after | |
| Oct 16, 2025 (view filing) | Oct 16 | Same day | Plavsic MarkChief Technology Officer | SSale | −12.2K | $6.35 | −$77.3K | −5.8%197.3K after | |
| Aug 18, 2025 (view filing) | Aug 18 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −7.72K | $6.70 | −$51.7K | −8.2%86.6K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | Johnson David MichaelDirector | PPurchase | +20.0K | $4.90 | +$98.0K | +13.7%166.2K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | Johnson David MichaelDirector | PPurchase | +5.00K | – | – | –5.00K after | Derivative |
| May 20, 2025 (view filing) | May 16 | 4 days | Gibney Anthony SSee Remarks | PPurchase | +50.0K | $4.90 | +$245.0K | +591.6%58.5K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | Gibney Anthony SSee Remarks | SSale | −1.52K | $5.15 | −$7.82K | −2.6%56.9K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | Gibney Anthony SSee Remarks | PPurchase | +12.5K | – | – | –12.5K after | Derivative |
| Apr 16, 2025 (view filing) | Apr 16 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −897 | $5.49 | −$4.92K | −1.1%81.4K after | |
| Apr 16, 2025 (view filing) | Apr 16 | Same day | Kilroy ConorSee Remarks | SSale | −7.16K | $5.49 | −$39.3K | −3.8%179.3K after | |
| Feb 18, 2025 (view filing) | Feb 18 | Same day | Plavsic MarkChief Technology Officer | SSale | −2.15K | $7.75 | −$16.7K | −1.0%209.5K after | |
| Feb 18, 2025 (view filing) | Feb 18 | Same day | Elazzouzi AmySenior Vice President, Finance | SSale | −1.40K | $7.75 | −$10.9K | −1.7%82.3K after | |
| Feb 18, 2025 (view filing) | Feb 18 | Same day | Hopkins Janet JillChief Medical Officer | SSale | −2.53K | $7.75 | −$19.6K | −0.9%269.8K after | |
| Feb 18, 2025 (view filing) | Feb 18 | Same day | de los Pinos ElisabetSee Remarks | SSale | −20.2K | $7.75 | −$156.7K | −4.0%482.4K after | |
| Jan 21, 2025 (view filing) | Jan 21 | Same day | de los Pinos ElisabetSee Remarks | SSale | −16.0K | $7.67 | −$122.4K | −5.0%304.7K after | |
| Jan 21, 2025 (view filing) | Jan 21 | Same day | Elazzouzi AmyVice President, Finance | SSale | −1.00K | $7.67 | −$7.68K | −2.5%38.4K after | |
| Nov 18, 2024 (view filing) | Nov 18 | Same day | Hopkins Janet JillChief Medical Officer | SSale | −11.8K | $9.36 | −$110.7K | −7.2%151.7K after | |
| Oct 29, 2024 (view filing) | Oct 29 | Same day | de los Pinos ElisabetSee Remarks | SSale | −9.20K | $10.74 | −$98.8K | −2.8%320.6K after | |
| Oct 29, 2024 (view filing) | Oct 29 | Same day | Elazzouzi AmyVice President, Finance | SSale | −553 | $10.74 | −$5.94K | −1.4%39.4K after | |
| Oct 21, 2024 (view filing) | Oct 18 | 3 days | Feder Julie BChief Financial Officer | SSale | −25.1K | $12.03 | −$302.3K | −15.8%134.3K after | 10b5-1 |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | de los Pinos ElisabetSee Remarks | SSale | −25.0K | $12.04 | −$300.9K | −7.0%329.8K after | 10b5-1 |
| Oct 16, 2024 (view filing) | Oct 16 | Same day | Plavsic MarkChief Technology Officer | SSale | −7.38K | $9.85 | −$72.7K | −5.7%121.1K after | |
| Jan 24, 2024 (view filing) | Jan 23 | 1 day | de los Pinos ElisabetSee Remarks | SSale | −15.9K | $7.64 | −$121.1K | −8.9%161.4K after | |
| Jan 24, 2024 (view filing) | Jan 23 | 1 day | Feder Julie BChief Financial Officer | SSale | −6.61K | $7.64 | −$50.5K | −9.5%63.0K after | |
| Nov 9, 2023 (view filing)4:35 PM ET | Nov 9 | Same day | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.00001 per share (Common Stock) | +1.56M | $9.00 | +$14.0M | +29.1%6.92M after | |
| Nov 9, 2023 (view filing) | Nov 7-8 | 2 days | Johnson David MichaelDirector | PPurchase | +85.6K | $7.18 | +$615.0K | +171.0%135.7K after | 2 lots |
| Nov 9, 2023 (view filing) | Nov 7-8 | 2 days | Johnson David MichaelDirector | PPurchase | +114.0K | $7.19 | +$820.0K | New position75.0K after | 4 lots |
| Nov 7, 2023 (view filing) | Nov 6 | 1 day | de los Pinos ElisabetSee Remarks | SSale | −7.45K | $12.03 | −$89.6K | −4.0%177.3K after | 10b5-1 |
| Nov 7, 2023 (view filing) | Nov 6 | 1 day | Feder Julie BChief Financial Officer | SSale | −3.90K | $12.07 | −$47.1K | −5.3%69.6K after | 10b5-1 |
| Nov 1, 2023 (view filing) | Oct 30 | 2 days | Feder Julie BChief Financial Officer | SSale | −3.38K | $6.82 | −$23.1K | −4.6%69.6K after | |
| Nov 1, 2023 (view filing) | Oct 30 | 2 days | de los Pinos ElisabetSee Remarks | SSale | −9.59K | $6.83 | −$65.5K | −5.0%180.9K after | |
| Oct 5, 2023 (view filing) | Oct 3-4 | 2 days | Johnson David MichaelDirector | PPurchase | +20.1K | $8.38 | +$168.2K | +66.9%50.1K after | 2 lots |
| Jan 9, 2023 (view filing) | Jan 5-6 | 4 days | Johnson David MichaelDirector | PPurchase | +2.00K | $10.41 | +$20.8K | +12.5%18.0K after | 4 lots |
| Dec 30, 2022 (view filing) | Dec 28 | 2 days | Johnson David MichaelDirector | PPurchase | +4.00K | $9.75 | +$39.0K | +30.8%17.0K after | 2 lots |
| Dec 15, 2022 (view filing) | Dec 1 | 14 daysLate | Johnson David MichaelDirector | PPurchase | +10.0K | $12.37 | +$123.7K | +200.0%15.0K after | 2 lots |
| Dec 7, 2022 (view filing)4:30 PM ET | Dec 5 | 2 days | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.00001 per share ("Common Stock") | +1.25M | $12.00 | +$15.0M | +30.4%5.36M after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Feder Julie BChief Financial Officer | SSale | −2.02K | $12.45 | −$25.1K | −7.7%24.2K after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Rich CadmusSee Remarks | SSale | −1.67K | $12.45 | −$20.8K | −6.4%24.6K after |